Searched for
CIPLA HEALTH
Is India Inc's CSR truly driving systemic change or just shifting funds?Corporate India is entering a new phase of CSR. Spending is expected to cross ₹1.2 lakh crore by 2035. Companies are shifting towards syste...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Cipla Q4 net profit slumps 55% YoY to Rs 555 crore, full-year PAT down 26%Pharma major Cipla announced a significant 55% drop in its net profit for the March quarter. Total income also saw a 3% decrease. For the f...
- Cipla Q4 profit drops 55% to Rs 555 crore; board recommends Rs 13 dividendCipla's fourth-quarter net profit saw a significant drop of 55 percent year-on-year. For the full financial year, the company's profit also...
- Cipla Q4 Results: Profit falls 55% YoY to Rs 555 crore; co declares Rs 13/sh dividendCipla Ltd announced a significant 55% year-on-year drop in its consolidated net profit for the fourth quarter, reaching Rs 555 crore. This ...
- Pharma Q4 outlook mixed: Hospitals steady, generics face revlimid dragIndian pharma and healthcare firms face a mixed March quarter. While hospitals anticipate steady growth, generic drugmakers grapple with lo...
- Cipla gets USFDA nod for generic respiratory issues treatment inhalation aerosolPharma major Cipla has secured final approval from the US health regulator for its generic albuterol sulfate inhalation aerosol. This marks...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Cancer drug makers seek 50% price hike as platinum surge hits production viabilityLocal drug manufacturers are struggling to produce essential cancer medicines like carboplatin and cisplatin due to a significant surge in ...
- Cipla's MK Hamied resigns from the company due to health reasonsCipla's Vice Chairman and Non-Executive Director, Mr. M K Hamied, has resigned from his position due to age and health reasons. His resigna...
- Cipla to acquire Ivia Beaute's cosmetics, personal care distribution, and marketing business for Rs 130 croreThis strategic move is aligned with Cipla's focus on enhancing its consumer healthcare and wellness portfolio, it added. The acquisition wi...
- Cipla to acquire nutritional supplement brand Endura MassEndura and all other associated trademarks would be part of the acquisition. CHL will initiate the distribution and marketing of the Endura...
- Nicotex joins hands with Karnataka, Goa governments to encourage smoking cessation with NRTTo promote safe behaviour, Nicotex has collaborated with the efforts of Karnataka to protect the frontline workers, who are presently engag...
- Cipla Health partners Swiggy, Zomato, Dunzo for home delivery of OTC wellness productsA home-delivery system makes it very convenient and safe for customers to get access to the wellness products, which otherwise might be dif...
- Cipla completes share allocation to FIL Capital InvestmentsCipla today said its arm Cipla Health has completed allocation of shares to FIL Capital Investments II Ltd. It inked an investment agreemen...
- Govt approves investment by FIL Capital in Cipla HealthDrug major Cipla today said the government has approved an investment by Mauritius-based FIL Capital Investments in its subsidiary, Cipla H...
- Cipla gets CCI nod to sell 26% in consumer healthcare businessDrug major Cipla has received approval from fair trade regulator CCI to sell about 26% stake in its consumer healthcare business to FIL Cap...
- Cipla to transfer consumer healthcare business to subsidiaryCipla Health was incorporated on August 27, 2015 to focus on the consumer healthcare space.
- Cipla inks investment pact with FIL Capital for its consumer healthcare businessCipla said it has inked an investment agreement with FIL Capital Investments (Mauritius) II Limited for its consumer healthcare business.
- Cipla in pink of healthCipla’s revenues are growing at a healthy rate, but higher growth in expenditure is tempering profit growth.
Load More
